Delivery Order SPE2DB20D2014-SPE2DB24FB04C
Award Date 2/8/24
Potential Completion Date 2/9/24
Potential Value $10K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,914.54 and is for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract is a firm fixed price, delivery order type, with a period of performance through February 2, 2024. This contract is not designated as a set-aside....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The $8,695.90 firm fixed-price contract has an ultimate completion date of January 29, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $5,590.80 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a ceiling value of $6,950.92 and an ultimate completion date of September 6, 2024. It is a firm fixed-price contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract has a ceiling value of $10,085.89 and a completion date of May 29, 2025. It is a firm-fixed-price contract, indicating a predetermined payment amount. The contract is not designated as a set-aside, meaning it was competitively awarded. AmerisourceBergen Drug Corp...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a brand-name pharmaceutical product, with a potential value of $34,834.73 and a completion date of February 1, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,205.13, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a pharmaceutical product. The contract has a completion date of November 20, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a for-profit organization registered in the System for Award Management...
- The Defense Logistics Agency (DLA) awarded a $3,598.68 firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide HUMULIN R 500 UNIT/ML KWIKPEN 3ML. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with DLA to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of HUMULIN R 500 UNIT/ML KWIKPEN 3ML medical products. The contract has a completion date of February 8, 2024 and a potential value of $8,945.28. This delivery order is issued under an existing indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, valued at up to $999,999,999.00 with a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,743.80, is for the delivery of HUMULIN R 500 UNIT/ML KWIKPEN 3ML, a diabetes medication. The contract is a firm-fixed price contract with a completion date of June 26, 2025. The contract is not set aside for any particular business category. AmerisourceBergen Drug Corp holds a significant...
- SPE2DB20D2014Indefinite Delivery Contract
- SPE2DB20D2014-SPE2DB24FB04CDelivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of HUMULIN R 500 UNIT/ML KWIKPEN 3ML. The contract has a firm fixed price pricing type and a potential value of $10,297.68. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Generated 5/9/24, 9:20 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.3k | 2/8/24 |